Rigel Pharmaceuticals
RIGL
#6623
Rank
HK$6.34 B
Marketcap
HK$336.74
Share price
-1.85%
Change (1 day)
1.90%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2026 (TTM): HK$137.57

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$138.63. In 2025 the company made an earnings per share (EPS) of HK$158.80 an increase over its 2024 EPS that were of HK$7.77.

EPS history for Rigel Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$137.57-13.37%
2025HK$158.801944.44%
2024HK$7.77
2022-HK$26.68240%
2021-HK$7.85-37.5%
2020-HK$12.55-60%
2019-HK$31.38-11.11%
2018-HK$35.31-26.23%
2017-HK$47.86-17.57%
2016-HK$58.0625.42%
2015-HK$46.29-42.72%
2014-HK$80.81
2012-HK$104.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
HK$136.36-1.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$55.86-59.71%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-HK$2.98-102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-HK$14.83-110.70%๐Ÿ‡บ๐Ÿ‡ธ USA